Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
| DUOPHARMA BIOTECH BERHAD |
Particulars of substantial Securities Holder
| Name | EMPLOYEES PROVIDENT FUND BOARD |
| Address |
TINGKAT 19, BANGUNAN KWSP, JALAN RAJA LAUT
KUALA LUMPUR 50350 Wilayah Persekutuan Malaysia. |
| Company No. | EPF ACT 1991 |
| Nationality/Country of incorporation | Malaysia |
| Descriptions (Class) | Ordinary Shares |
Details of changes
| No | Date of change | No of securities |
Type of Transaction | Nature of Interest |
| 20 Oct 2020 | 76,000 |
Disposed | Direct Interest | |
| Name of registered holder | Citigroup Nominees (Tempatan) Sdn. Bhd. | |||
| Address of registered holder | Level 42, Menara Citibank, 165 Jalan Ampang, 50450 Kuala Lumpur. | |||
| Description of "Others" Type of Transaction | ||||
| 20 Oct 2020 | 128,900 |
Acquired | Direct Interest | |
| Name of registered holder | Citigroup Nominees (Tempatan) Sdn. Bhd. | |||
| Address of registered holder | Level 42, Menara Citibank, 165 Jalan Ampang, 50450 Kuala Lumpur. | |||
| Description of "Others" Type of Transaction | ||||
| Circumstances by reason of which change has occurred | Disposal of 76,000 shares by Citigroup Nominees (Tempatan) Sdn. Bhd. - Employees Provident Fund Board Acquisition of 128,900 shares by Citigroup Nominees (Tempatan) Sdn. Bhd. - Employees Provident Fund Board (CIMB PRI) |
| Nature of interest | Indirect Interest |
| Direct (units) | |
| Direct (%) | |
| Indirect/deemed interest (units) | 54,007,216 |
| Indirect/deemed interest (%) | 7.649 |
| Total no of securities after change | 54,007,216 |
| Date of notice | 21 Oct 2020 |
| Date notice received by Listed Issuer | 23 Oct 2020 |
| Remarks : |
Total number of Duopharma Biotech Berhad shares held are as follows:- (a) CITIGROUP NOMINEES (TEMPATAN) SDN. BHD. EMPLOYEES PROVIDENT FUND BOARD : 44,812,570 (b) CITIGROUP NOMINEES (TEMPATAN) SDN. BHD. EMPLOYEES PROVIDENT FUND BOARD (CIMB PRI) : 7,985,646 (c) CITIGROUP NOMINEES (TEMPATAN) SDN. BHD. EMPLOYEES PROVIDENT FUND BOARD (CPIAM EQ) IC. : 1,200,000 |
Announcement Info
| Company Name | DUOPHARMA BIOTECH BERHAD |
| Stock Name | DPHARMA |
| Date Announced | 23 Oct 2020 |
| Category | Change in the Interest of Substantial Shareholder Pursuant to Section 138 of CA 2016 |
| Reference Number | CS2-23102020-00034 |